七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证)的临床观察
本文选题:七消饮加味 + 中药溻渍 ; 参考:《长春中医药大学》2016年硕士论文
【摘要】:目的:本课题采用“益气化瘀,利水消鼓”的治法,应用自拟方七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证),通过临床观察,客观评价七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证)的安全性及有效性。为肝硬化腹水规范的治疗方案寻求更为有利的依据。方法:对就诊于我院肝脾胃病科病房肝硬化腹水(气虚血瘀证)的符合条件的72例患者按照随机分组原则将其分为2组,其中对照组36例,治疗组36例,两组患者均治疗4周。对照组给予保肝降酶药物静点、利尿剂口服。治疗组在对照组的基础上加用中药七消饮加味配合红外线照射中药溻渍腹部疗法。治疗四周后,通过记录治疗前、后患者的体重、腹围、腹水彩超、肝功能、主要症状及次要症状等的改善情况。以分析总结出七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证)的有效性及安全性。结果:1)、安全性观察:对两组患者治疗前后安全性指标进行观察,显示两组患者在治疗的过程中均未出现任何不良事件。2)、总体疗效比较:对照组36例患者,其中临床治愈6例,显效10例,有效16例,无效4例。治疗组36例患者临床治愈10例,显效18例,有效6例,无效2例。对照组临床治愈率16.7%,显效率27.8%,有效率44.4%,无效率:11.1%。治疗组临床治愈率27.8%,显效率50%,有效率16.6%,无效率:5.6%。对照组总有效率:88.9%,治疗组总有效率:94.4%。治疗组效果优于对照组,且具有统计学意义(P0.05)。3)、治疗后中医单项症状的改善:面色晦暗这一症状的改善,两组治疗效果未见明显的统计学差异(P0.05)。但是,在腹大胀满、神疲乏力、头颈胸间紫斑、食后腹胀、小便短少这5个症状改善方面,治疗组的效果明显优于对照组,有统计学意义(P0.05)。4)、治疗后各项疗效指标比较:在降低门静脉内径方面两组治疗效果未见明显的统计学差异(P0.05),但是两组患者在改善肝功能(TBIL、ALT、AST、GGT、ALB)、缩小腹围、减轻体重、增加24小时尿量、减低彩超下腹水量方面,治疗组效果明显优于对照组,有统计学差异(P0.05)。结论:由以上数据经过分析得出:七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证)在消退腹水,改善肝功能各项指标,缓解症状等方面安全有效。进一步客观评价了七消饮加味配合中药溻渍治疗肝硬化腹水(气虚血瘀证)的安全性及疗效,从而证明了其在治疗肝硬化腹水(气虚血瘀证)方面的优势。
[Abstract]:Objective: to use the method of "invigorating qi and removing blood stasis, and promoting water to remove the drum", and to treat ascites of liver cirrhosis (Qi deficiency and blood stasis syndrome) with modified Qixiao decoction and traditional Chinese medicine, and to observe it through clinical observation. Objective to evaluate the safety and efficacy of Qixiaoyin Jiawei combined with traditional Chinese medicine in the treatment of ascites of liver cirrhosis (qi deficiency and blood stasis syndrome). To find a more favorable basis for the standard treatment of ascites due to cirrhosis. Methods: 72 patients with cirrhotic ascites (Qi deficiency and blood stasis syndrome) were randomly divided into two groups: control group (36 cases), treatment group (36 cases) and treatment group (36 cases). The control group was treated with liver protection drug and diuretic orally. On the basis of the control group, the treatment group was treated with traditional Chinese medicine Qixiaoyin plus infrared radiation. After four weeks of treatment, the improvement of weight, abdominal circumference, ascites color Doppler ultrasound, liver function, main symptoms and secondary symptoms were recorded before and after treatment. The efficacy and safety of Qixiaoyin Jiawei combined with traditional Chinese medicine Tarim stains in treating ascites of liver cirrhosis (qi deficiency and blood stasis syndrome) were summarized. Results: the safety indexes of the two groups of patients before and after treatment were observed. The results showed that there were no adverse events in both groups. The overall curative effect was compared: 36 patients in the control group, 6 patients were clinically cured. There were 10 cases of remarkable effect, 16 cases of effective and 4 cases of failure. In the treatment group, 10 cases were clinically cured, 18 cases were effective, 6 cases were effective and 2 cases were ineffective. In the control group, the clinical cure rate was 16.7g, the apparent efficiency was 27.8m, the effective rate was 44.4, and the inefficiency was: 11.1. In the treatment group, the clinical cure rate was 27.8%, the markedly effective rate was 50%, the effective rate was 16.6b, and the inefficiency was 5.6%. The total effective rate of the control group was 88.9 and the total effective rate of the treatment group was 94.4. The effect of the treatment group was better than that of the control group, and it had statistical significance (P 0.05). After treatment, the single symptom of TCM was improved: the symptom of dark complexion was improved, and there was no significant difference in the treatment effect between the two groups (P 0.05). However, the effect of the treatment group was significantly better than that of the control group in the five symptoms of abdominal bulge, fatigue, purple spots between the head, neck and chest, abdominal distension after eating and short urination. There was no significant difference in the therapeutic effect between the two groups in reducing the diameter of portal vein after treatment. However, the two groups were improving liver function by TBILALTASTASTGGTT ALB, reducing abdominal circumference, reducing body weight, and increasing 24 hours urine volume, and compared with the control group, the patients in the two groups had no significant difference in the effect of treatment on reducing the diameter of portal vein (P0. 05%, P 0. 05%, P 0. 05%, P 0. 05%, P 0. 05, P 0. 05). The effect of the treatment group was better than that of the control group (P 0.05). Conclusion: through the analysis of the above data, it is concluded that Qixiaoyin Jiawei combined with traditional Chinese medicine Tarim stains is safe and effective in the treatment of ascites of liver cirrhosis (qi deficiency and blood stasis syndrome), improving various indexes of liver function and alleviating symptoms. The safety and curative effect of Qixiaoyin Jiawei combined with traditional Chinese medicine Tarim stains in treating ascites of liver cirrhosis (Qi deficiency and blood stasis syndrome) were evaluated objectively, which proved its superiority in treating cirrhosis ascites (Qi deficiency and blood stasis syndrome).
【学位授予单位】:长春中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 丁庆学;中西医结合治疗肝硬化腹水64例[J];光明中医;2000年04期
2 ;肝硬化腹水[J];广西中医药;2000年02期
3 闫培林;扶正消臌汤治疗肝硬化腹水42例[J];实用中医内科杂志;2000年01期
4 孙玉柱;肝硬化腹水治疗的体会[J];现代中西医结合杂志;2000年11期
5 王丽莉,王莉,于景献;中西医结合治疗肝硬化腹水34例[J];中医药信息;2000年02期
6 杨勇;肝硬化腹水加药物直接回输180例治疗体会[J];陕西医学杂志;2001年02期
7 谢梦洲,金红,雷立芳;中西医结合治疗肝硬化腹水的疗效观察[J];辽宁中医杂志;2001年03期
8 王绍粉,陈运明,吴绍云;中西医结合治疗肝硬化腹水69例[J];时珍国医国药;2001年04期
9 杨丽华 ,吕维斌;中药保留灌肠治疗肝硬化腹水[J];云南中医中药杂志;2001年05期
10 刘苏,刘皖生,吴晓峰;自拟软肝消臌汤配合西医治疗肝硬化腹水20例[J];安徽中医临床杂志;2002年05期
相关会议论文 前10条
1 张先广;;中西医结合治疗肝硬化腹水36例[A];全国第2届中西医结合传染病学术会议暨国家中医药管理局第1届传染病协作组会议论文汇编[C];2008年
2 丁静;许兴国;孙聪;徐立明;;中西医结合治疗肝硬化腹水30例分析[A];第二届浙江省消化病学术大会论文汇编[C];2009年
3 欧吕基;;中西医结合治疗肝硬化腹水26例[A];中华中医药学会第十三届内科肝胆病学术会议论文汇编[C];2008年
4 黄穗平;余绍源;;肝硬化腹水的治疗[A];中华中医药学会第二十一届全国脾胃病学术交流会暨2009年脾胃病诊疗新进展学习班论文汇编[C];2009年
5 黄遵仁;;肝硬化腹水并发自发性细菌性腹膜炎45例临床浅析[A];第二届传染病诊治高峰论坛暨2009年浙江省感染病、肝病学术年会论文汇编[C];2009年
6 韩瑞星;;临床治疗肝硬化腹水300例小结[A];中国中医药学会建会20周年学术年会专辑(下)[C];1999年
7 孙新民;刘贤凤;;中西医结合治疗肝硬化腹水47例[A];第二十二届全国中西医结合消化系统疾病学术会议暨消化疾病诊治进展学习班论文汇编[C];2010年
8 谷井文;黄崇元;;中西医结合辨治肝硬化腹水46例[A];第六届全国中西医结合基础理论研究学术研讨会暨第二届湖南省中西医结合学会肝病专业学术年会论文集[C];2010年
9 唐兴全;;中西医结合治疗肝硬化腹水48例[A];中国中西医结合学会第十二次全国消化系统疾病学术研讨会论文汇编[C];2000年
10 王伟;;自拟三臌汤治疗肝硬化腹水[A];全国第七届农村基层中西医结合学术暨工作交流会论文汇编集[C];2002年
相关重要报纸文章 前10条
1 陈斌;肝硬化腹水的诊治[N];大众卫生报;2007年
2 陈冠林邋许仕杰;周福生“三位一体”辨治肝硬化腹水[N];中国中医药报;2007年
3 海熙;治早期肝硬化腹水[N];民族医药报;2004年
4 粤北第二人民医院副主任医师 陈卓鹏;肝硬化腹水的后期治疗[N];韶关日报;2005年
5 关继波;扶正为主治疗肝硬化腹水[N];健康报;2005年
6 蒲春;治肝硬化腹水方[N];民族医药报;2003年
7 上海中医药大学曙光医院肝病研究所 刘成海教授;肝硬化腹水可以用中药辨证敷脐法治疗[N];上海中医药报;2004年
8 明秀;治肝硬化腹水民间方[N];民族医药报;2009年
9 ;中西医结合治疗肝硬化腹水可弥补西药不足[N];中国中医药报;2004年
10 艳文;治肝硬化腹水小方[N];民族医药报;2001年
相关博士学位论文 前4条
1 孙剑勇;肝硬化腹水大鼠水通道蛋白研究及特利加压素作用机制探讨[D];复旦大学;2002年
2 杨小红;健脾活血利水法治疗肝硬化腹水的理论与临床研究[D];南京中医药大学;2005年
3 符小聪;健脾益肝方对肝硬化腹水NO及ET-1调节的相关性研究[D];广州中医药大学;2008年
4 张爱娟;晚清民国时期和1978年后文献关于鼓胀(肝硬化腹水)的诊治规律研究[D];广州中医药大学;2015年
相关硕士学位论文 前10条
1 苏飞;肝硬化腹水中医辨证分型与客观指标的相关性研究[D];河北医科大学;2015年
2 李振前;“消肿散”外敷对肝硬化腹水临床疗效的研究[D];安徽中医药大学;2015年
3 梁燕;浊霾散敷脐联合艾灸法治疗鼓胀(乙肝肝硬化腹水)的疗效评价[D];华北理工大学;2015年
4 都嵬;中医药治疗肝硬化腹水组方配伍规律的现代文献数据挖掘研究[D];辽宁中医药大学;2015年
5 王天柱;通络利水法在肝硬化腹水临床中的应用探讨[D];湖北中医药大学;2015年
6 孙洁;基于数据挖掘的名老中医治疗肝硬化腹水临床经验研究[D];南京中医药大学;2016年
7 管佳畅;复肝春3号方对肝硬化腹水大鼠AQP8、ET-1、NO的影响[D];河北医科大学;2016年
8 程欢迎;脐火疗法治疗脾肾阳虚型肝硬化腹水的临床研究[D];河南中医药大学;2016年
9 赵玲玲;隔姜灸联合温阳逐水膏穴位贴敷治疗肝硬化腹水的临床疗效评价[D];河南中医药大学;2016年
10 连丽;红外线照射中药溻渍疗法治疗乙肝肝硬化腹水(气滞湿阻证)的临床研究[D];长春中医药大学;2016年
,本文编号:1850150
本文链接:https://www.wllwen.com/zhongyixuelunwen/1850150.html